Astellas US LLC et al v. Aurobindo Pharma Limited

Plaintiff: Astellas US LLC, Astellas Pharma US Inc. and Gilead Sciences, Inc.
Defendant: Aurobindo Pharma Limited
Case Number: 1:2021cv01269
Filed: September 3, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on September 3, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 3, 2021 Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (apk)
September 3, 2021 Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US Inc., Astellas US LLC filed by Astellas Pharma US Inc., Astellas US LLC. (apk)
September 3, 2021 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/10/2021. Date of Expiration of Patent: 02/2/2027.Thirty Month Stay Deadline: 2/9/2024. (apk)
September 3, 2021 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
September 3, 2021 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3692322.) - filed by Astellas US LLC, Astellas Pharma US Inc., Gilead Sciences, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(apk)
September 3, 2021 No Summons Issued. (apk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Astellas US LLC et al v. Aurobindo Pharma Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Astellas US LLC
Represented By: Kelly A Del Dotto
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Astellas Pharma US Inc.
Represented By: Kelly A Del Dotto
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Gilead Sciences, Inc.
Represented By: Kelly A Del Dotto
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma Limited
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?